Lakefront Biotherapeutics (LKFT) Intangibles (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has 13 years of Intangibles data on file, last reported at $873376.3 in Q1 2026.

• Intangibles for Q1 2026 came in at $873376.3, down 99.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $873376.3 (down 99.47% YoY), and the FY2025 annual result was $987108.9, down 99.44% from the prior year.
• Intangibles declined to $873376.3 in Q1 2026 per LKFT's latest filing, from $987108.9 in the prior quarter.
• Over five years, Intangibles peaked at $190.5 million in Q3 2024 and troughed at -$15.5 million in Q4 2022.
• A 5-year average of $95.2 million and a median of $136.9 million in 2024 frame the typical range for Intangibles.
• The sharpest annual moves came in 2022 and 2023: Intangibles sank 423.05% in 2022, then jumped 399.33% in 2023.
• A 5-year view of Intangibles shows it stood at -$15.5 million in 2022, then jumped by 399.33% to $46.4 million in 2023, then jumped by 279.27% to $176.2 million in 2024, then slumped by 99.44% to $987108.9 in 2025, then decreased by 11.52% to $873376.3 in 2026.
• Business Quant data shows LKFT's Intangibles at $873376.3 in Q1 2026, $987108.9 in Q4 2025, and $8.7 million in Q3 2025.